Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
2.320
+0.110 (4.98%)
At close: May 13, 2025, 4:00 PM
2.300
-0.020 (-0.86%)
Pre-market: May 14, 2025, 8:33 AM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $100.27 million as of May 14, 2025. Its market cap has decreased by -85.41% in one year.
Market Cap
100.27M
Enterprise Value
-135.44M
1-Year Change
-85.41%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $100.27M, a decrease of -88.84%. That is a compound annual growth rate of -82.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 95.51M | -40.84% |
| Dec 31, 2024 | 161.46M | -82.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |